Medtech Talk
A weekly conversation with the innovators who will change how health care is delivered.
- Update frequency
- every 25 days
- Average duration
- 38 minutes
- Episodes
- 200
- Years Active
- 2015 - 2025
Medtech VCs Klein, Nielsen Explain Why They Decided to Start Up Their Own Venture Firm, Vensana
Justin Klein and Kirk Nielsen entered venture capital separately 13 years ago, taking roles at two of the top firms in Medtech. Over that time, the two VCs have led investment in more than a dozen Me…
Stryker’s Kevin Lobo Explains Why He Calls Medtech Home, How the “Serial Acquirer” Will Keep Growing
Growing up in Canada, Kevin Lobo only knew he wanted to be a senior executive at a global company someday. That overriding objective took him through the consumer good and chemical industries before …
We Hope to See You Next Week at the Medtech Conference
Thank you for your support of the MedtechTalk Podcast. We hope to see you at the Medtech Conference next week. We’ll be posting compelling interviews with Medtech’s leaders immediately after the conf…
GE Healthcare’s Agnes Berzsenyi Is Clearly Comfortable with Changing Women’s Healthcare
In this week’s podcast, Agnes Berzsenyi, president and CEO of Women’s Health at GE Healthcare, explains how her upbringing in Hungary during a time of political upheaval put her in position to succee…
Gelfand and Levin Share Lessons from Ardian’s Rise and Fall…and Rise Again. Would They Do It Again?
Howard Levin and Mark Gelfand, the principals of Coridea, return to the podcast to detail the trials and tribulations of Ardian. Ardian is one of the bigger #medtech #startup stories over the past tw…
Mark Gelfand, Howard Levin Discuss Coridea, Ardian and How They’re Innovating Medtech Innovation
Over the past decade, no other Medtech start-up has moved markets as much or as quickly as Ardian, the godfather of the renal denervation surge a decade ago. But the gold rush dried up in 2014 when M…
Shyam Natarajan, CEO and Founder of Avenda Health, Explains How the Start-Up is Gaining Momentum
In this episode of the MedtechTalk Podcast, we talk with Shyam Natarajan, PhD, founder and CEO of Avenda Health, a company using imaging, AI and focal lasers to create a better treatment for prostate…
Nuvaira’s Dennis Wahr Gives Presenting Tips, IDs his Role Models, Talks About Possibly Going Public
You’ll have a hard time finding a more modest man than Dennis Wahr, president and CEO of Nuvaira. But when asked what company he sees as being poised to establish the Interventional Pulmonology indus…
Go Go Go! Scott Huennekens Explains How Strong Bias to Action Defined Leadership at Volcano, Verb
Anyone who has swapped emails with Scott Huennekens has seen the Go Go Go signature at the bottom. They’re three little words, but they say so much about the special brand of enthusiasm Huennekens br…
KPV’s Amy Belt Raimundo Landed in VC Just Before the Bottom Fell Out. Hear How She Pivoted, Thrived
No, Amy Belt Raimundo didn’t blow anything up. But she knew early on in college that her initial career choice of chemistry wasn’t her true path. Instead, she earned an economics degree, and used ins…
Invus Opportunities Partner Ben Tsai Seeks – and Finds – Success in Medtech Investments
Benjamin Tsai says his initial plans – or the plans he’d been given – called on him being a doctor. But he quickly saw a greater opportunity working in the life sciences industry. Tsai made a quick r…
PreCardia CEO Lisa Wipperman Heine Shares Details on Path to New Role at Stealthy HF Start-Up
Lisa Wipperman Heine’s career in Medtech was launched when she answered a want ad in a newspaper – remember those? That path took her to top regulatory and clinical affairs positions at several high…
Medtech Incubator NXT Biomedical Shows Stan Rowe Is Great at Innovation, Bad at “Retirement”
After leading a long, distinguished and successful career in Medtech Innovation, Stan Rowe chose a familiar, if not unusual, spot to “retire” – he co-founded NXT Biomedical, an incubator backed by De…
GT Medical CEO Matt Likens Sets a New BHAG – Giving Longer Lives to People with Brain Tumors
Matt Likens’ two decades-plus at Baxter cultivated in him a desire to deliver “critical therapies for life-threatening conditions.” He found great success as CEO of Ulthera, an aesthetics company usi…
Merit Medical CEO Fred Lampropoulos Lays Out Aggressive Growth Strategy, Including Opportunistic M&A
Spoiler Alert: I missed a huge part of Merit Medical CEO Fred Lampropoulos’ life story when I did my research. I won’t say what it was, but you’ll hear it at the end. I’d fire my researcher if I had …
Santé Ventures’ James Eadie, MD, Reveals the Early-Stage Strategy That’s Producing Epic Returns
Santé Ventures partner James Eadie, MD, doesn’t recall the good old days of Medtech. He joined the Austin-based Venture Firm after two tours in Iraq with the Air Force where he led an ER and served a…
SVB’s Jon Norris Reveals Medtech’s Most Prolific Investors, Hottest Areas, and Biggest Exits
Earlier this month, Silicon Valley Bank released its Trends in Healthcare Investments and Exits 2019, the latest of the bank’s annual reports on the state of healthcare investing. In this podcast we …
Miromatrix CEO Jeff Ross Shares the Bold Plan to Eliminate the Organ Transplant Waiting List
Miromatrix straddles the line between biotech and medtech. The start-up is developing a line of “ghost organs” that can be used in humans. The technology is moving fast, and Ross hopes to have clinic…
Alydia CEO Anne Morrissey Talks Car Accidents, Career Guidance and How the Start-up Raised $10m
Fortune disguised as misfortune led Anne Morrissey to embark on a Medtech career. Since that start, hard work, perseverance and some helpful mentors put her on the CEO track. Today, Morrissey leads a…
AEGEA CEO Maria Sainz Talks Guidant and the Rewards and Challenges of Leading a Medtech Start-up
Twenty years ago, Maria Sainz faced an unusual fork in her career road. She chose wisely, building an esteemed career in Medtech that included senior leadership at Guidant and CEO posts at three Medt…